CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral infections. HIV-infected individuals develop CTL responses against epitopes derived from viral proteins, but also against cryptic epitopes encoded by viral alternative reading frames (ARF). We studied here the mechanisms of HIV-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sylvain Cardinaud, Gesa Consiglieri, Romain Bouziat, Alejandra Urrutia, Stéphanie Graff-Dubois, Slim Fourati, Isabelle Malet, Julien Guergnon, Amélie Guihot, Christine Katlama, Brigitte Autran, Peter van Endert, François A Lemonnier, Victor Appay, Olivier Schwartz, Peter M Kloetzel, Arnaud Moris
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
Acceso en línea:https://doaj.org/article/11741e79371a421faecf68c1ab9f787a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11741e79371a421faecf68c1ab9f787a
record_format dspace
spelling oai:doaj.org-article:11741e79371a421faecf68c1ab9f787a2021-11-18T06:03:24ZCTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.1553-73661553-737410.1371/journal.ppat.1002049https://doaj.org/article/11741e79371a421faecf68c1ab9f787a2011-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21589903/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral infections. HIV-infected individuals develop CTL responses against epitopes derived from viral proteins, but also against cryptic epitopes encoded by viral alternative reading frames (ARF). We studied here the mechanisms of HIV-1 escape from CTLs targeting one such cryptic epitope, Q9VF, encoded by an HIVgag ARF and presented by HLA-B*07. Using PBMCs of HIV-infected patients, we first cloned and sequenced proviral DNA encoding for Q9VF. We identified several polymorphisms with a minority of proviruses encoding at position 5 an aspartic acid (Q9VF/5D) and a majority encoding an asparagine (Q9VF/5N). We compared the prevalence of each variant in PBMCs of HLA-B*07+ and HLA-B*07- patients. Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ than in HLA-B*07- patients, suggesting that Q9FV/5D encoding viruses might be under selective pressure in HLA-B*07+ individuals. We thus analyzed ex vivo CTL responses directed against Q9VF/5D and Q9VF/5N. Around 16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF epitopes. The frequency and the magnitude of CTL responses induced with Q9VF/5D or Q9VF/5N peptides were almost equal indicating a possible cross-reactivity of the same CTLs on the two peptides. We then dissected the cellular mechanisms involved in the presentation of Q9VF variants. As expected, cells infected with HIV strains encoding for Q9VF/5D were recognized by Q9VF/5D-specific CTLs. In contrast, Q9VF/5N-encoding strains were neither recognized by Q9VF/5N- nor by Q9VF/5D-specific CTLs. Using in vitro proteasomal digestions and MS/MS analysis, we demonstrate that the 5N variation introduces a strong proteasomal cleavage site within the epitope, leading to a dramatic reduction of Q9VF epitope production. Our results strongly suggest that HIV-1 escapes CTL surveillance by introducing mutations leading to HIV ARF-epitope destruction by proteasomes.Sylvain CardinaudGesa ConsiglieriRomain BouziatAlejandra UrrutiaStéphanie Graff-DuboisSlim FouratiIsabelle MaletJulien GuergnonAmélie GuihotChristine KatlamaBrigitte AutranPeter van EndertFrançois A LemonnierVictor AppayOlivier SchwartzPeter M KloetzelArnaud MorisPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 7, Iss 5, p e1002049 (2011)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Sylvain Cardinaud
Gesa Consiglieri
Romain Bouziat
Alejandra Urrutia
Stéphanie Graff-Dubois
Slim Fourati
Isabelle Malet
Julien Guergnon
Amélie Guihot
Christine Katlama
Brigitte Autran
Peter van Endert
François A Lemonnier
Victor Appay
Olivier Schwartz
Peter M Kloetzel
Arnaud Moris
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
description Cytotoxic CD8+ T cells (CTLs) play a critical role in controlling viral infections. HIV-infected individuals develop CTL responses against epitopes derived from viral proteins, but also against cryptic epitopes encoded by viral alternative reading frames (ARF). We studied here the mechanisms of HIV-1 escape from CTLs targeting one such cryptic epitope, Q9VF, encoded by an HIVgag ARF and presented by HLA-B*07. Using PBMCs of HIV-infected patients, we first cloned and sequenced proviral DNA encoding for Q9VF. We identified several polymorphisms with a minority of proviruses encoding at position 5 an aspartic acid (Q9VF/5D) and a majority encoding an asparagine (Q9VF/5N). We compared the prevalence of each variant in PBMCs of HLA-B*07+ and HLA-B*07- patients. Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ than in HLA-B*07- patients, suggesting that Q9FV/5D encoding viruses might be under selective pressure in HLA-B*07+ individuals. We thus analyzed ex vivo CTL responses directed against Q9VF/5D and Q9VF/5N. Around 16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF epitopes. The frequency and the magnitude of CTL responses induced with Q9VF/5D or Q9VF/5N peptides were almost equal indicating a possible cross-reactivity of the same CTLs on the two peptides. We then dissected the cellular mechanisms involved in the presentation of Q9VF variants. As expected, cells infected with HIV strains encoding for Q9VF/5D were recognized by Q9VF/5D-specific CTLs. In contrast, Q9VF/5N-encoding strains were neither recognized by Q9VF/5N- nor by Q9VF/5D-specific CTLs. Using in vitro proteasomal digestions and MS/MS analysis, we demonstrate that the 5N variation introduces a strong proteasomal cleavage site within the epitope, leading to a dramatic reduction of Q9VF epitope production. Our results strongly suggest that HIV-1 escapes CTL surveillance by introducing mutations leading to HIV ARF-epitope destruction by proteasomes.
format article
author Sylvain Cardinaud
Gesa Consiglieri
Romain Bouziat
Alejandra Urrutia
Stéphanie Graff-Dubois
Slim Fourati
Isabelle Malet
Julien Guergnon
Amélie Guihot
Christine Katlama
Brigitte Autran
Peter van Endert
François A Lemonnier
Victor Appay
Olivier Schwartz
Peter M Kloetzel
Arnaud Moris
author_facet Sylvain Cardinaud
Gesa Consiglieri
Romain Bouziat
Alejandra Urrutia
Stéphanie Graff-Dubois
Slim Fourati
Isabelle Malet
Julien Guergnon
Amélie Guihot
Christine Katlama
Brigitte Autran
Peter van Endert
François A Lemonnier
Victor Appay
Olivier Schwartz
Peter M Kloetzel
Arnaud Moris
author_sort Sylvain Cardinaud
title CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
title_short CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
title_full CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
title_fullStr CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
title_full_unstemmed CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
title_sort ctl escape mediated by proteasomal destruction of an hiv-1 cryptic epitope.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/11741e79371a421faecf68c1ab9f787a
work_keys_str_mv AT sylvaincardinaud ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT gesaconsiglieri ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT romainbouziat ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT alejandraurrutia ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT stephaniegraffdubois ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT slimfourati ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT isabellemalet ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT julienguergnon ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT amelieguihot ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT christinekatlama ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT brigitteautran ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT petervanendert ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT francoisalemonnier ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT victorappay ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT olivierschwartz ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT petermkloetzel ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
AT arnaudmoris ctlescapemediatedbyproteasomaldestructionofanhiv1crypticepitope
_version_ 1718424648949956608